Importer of Controlled Substances; Notice of Registration, 17472 [05-6798]
Download as PDF
<![CDATA[
17472
Federal Register / Vol. 70, No. 65 / Wednesday, April 6, 2005 / Notices
Delaware renamed the road where the
facility is located, thus causing the
address to change. The address should
be modified to read: Dade Behring Inc.,
100 GBC Drive MS514, Post Office Box
6101, Attention: RA/QS, Newark,
Delaware 19714–6101.
Dated: March 29, 2005.
William J. Walker,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. 05–6789 Filed 4–5–05; 8:45 am]
Dated: March 29, 2005.
William J. Walker,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. 05–6790 Filed 4–5–05; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances;
Notice of Registration
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances;
Notice of Registration
By notice dated November 8, 2004,
and published in the Federal Register
on November 22, 2004 (69 FR 67963),
ISP Freetown Fine Chemicals, 238
South Main Street, Assonet,
Massachusetts 02702, made application
by renewal to the Drug Enforcement
Administration (DEA) to be registered as
an importer of Phenylacetone (8501), a
basic class of controlled substance listed
in Schedule II.
The company plans to import
Phenylacetone to be used in the
manufacture of amphetamine.
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a) and 952(a)
and determined that the registration of
ISP Freetown Fine Chemicals to import
the basic classes of controlled
substances is consistent with the public
interest and with United States
obligations under international treaties,
conventions, or protocols in effect on
May 1, 1971, at this time. DEA has
investigated ISP Freetown Fine
Chemicals to ensure that the company’s
registration is consistent with the public
interest. The investigation has included
inspection and testing of the company’s
physical security systems, verification
of the company’s compliance with state
and local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C. 952(a)
and 958(a), and in accordance with 21
CFR 1301.34, the above named company
is granted registration as an importer of
the basic class of controlled substance
listed.
By notice dated February 17, 2005,
and published in the Federal Register
on February 28, 2005 (70 FR 9677–
9678), JFC Technologies, LLC, 100 West
Main Street, PO Box 669, Bound Brook,
New Jersey 08805, made application by
renewal to the Drug Enforcement
Administration (DEA) to be registered as
an importer of Meperidine-Intermediate
B (9233), a basic class of controlled
substance listed in Schedule II.
The company plans to import the
listed controlled substances for
manufacture of controlled substances in
bulk for distribution to its customers.
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a) and 952(a)
and determined that the registration of
JFC Technologies, LLC to import the
basic classes of controlled substances is
consistent with the public interest and
with United States obligations under
international treaties, conventions, or
protocols in effect on May 1, 1971, at
this time. DEA has investigated JFC
Technologies, LLC to ensure that the
company’s registration is consistent
with the public interest. The
investigation has included inspection
and testing of the company’s physical
security systems, verification of the
company’s compliance with state and
local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C. 952(a)
and 958(a), and in accordance with 21
CFR 1301.34, the above named company
is granted registration as an importer of
the basic class of controlled substance
listed.
Dated: March 29, 2005.
William J. Walker,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. 05–6798 Filed 4–5–05; 8:45 am]
BILLING CODE 4410–09–P
VerDate jul<14>2003
18:17 Apr 05, 2005
Jkt 205001
PO 00000
Frm 00071
Fmt 4703
Sfmt 4703
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled
Substances; Notice of Application;
Correction
The Notice dated December 21, 2004,
and published in the Federal Register
on January 4, 2005, (70 FR 393), the
drug code for Fentanyl was incorrect,
for Organichem Corporation, 33
Riverside Avenue, Rensselaer, New
York 12144. The correct drug code for
Fentanyl is (9801). The Notice of
Application should be corrected to
reflect Fentanyl (9801).
Dated: March 29, 2005.
William J. Walker,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. 05–6793 Filed 4–5–05; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances;
Notice of Application
Pursuant to 21 U.S.C. 958(i), the
Attorney General shall, prior to issuing
a registration under this Section to a
bulk manufacturer of a controlled
substance in Schedule I or II and prior
to issuing a registration under 21 U.S.C.
952 (a) (2) (B) authorizing the
importation of such a substance,
provide manufacturers holding
registrations for the bulk manufacture of
the substance an opportunity for a
hearing.
Therefore, in accordance with 21 CFR
1301.34(a), this is notice that on
February 1, 2005, Penick Corporation,
158 Mount Olivet Avenue, Newark,
New Jersey 07114, made application by
renewal to the Drug Enforcement
Administration (DEA) to be registered as
an importer of the basic classes of
controlled substances listed in
Schedules II:
Drug
Coca Leaves (9040) .....................
Raw Opium (9600) .......................
Poppy Straw (9650) .....................
Poppy Straw Concentrate (9670)
Schedule
II
II
II
II
The company plans to import the
listed controlled substances to
manufacturer bulk controlled
substances and non-controlled
substance flavor extracts.
Any manufacturer who is presently,
or is applying to be, registered with DEA
E:\FR\FM\06APN1.SGM
06APN1
]]>Agencies
[Federal Register Volume 70, Number 65 (Wednesday, April 6, 2005)]
[Notices]
[Page 17472]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-6798]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances; Notice of Registration
By notice dated February 17, 2005, and published in the Federal
Register on February 28, 2005 (70 FR 9677-9678), JFC Technologies, LLC,
100 West Main Street, PO Box 669, Bound Brook, New Jersey 08805, made
application by renewal to the Drug Enforcement Administration (DEA) to
be registered as an importer of Meperidine-Intermediate B (9233), a
basic class of controlled substance listed in Schedule II.
The company plans to import the listed controlled substances for
manufacture of controlled substances in bulk for distribution to its
customers.
No comments or objections have been received. DEA has considered
the factors in 21 U.S.C. 823(a) and 952(a) and determined that the
registration of JFC Technologies, LLC to import the basic classes of
controlled substances is consistent with the public interest and with
United States obligations under international treaties, conventions, or
protocols in effect on May 1, 1971, at this time. DEA has investigated
JFC Technologies, LLC to ensure that the company's registration is
consistent with the public interest. The investigation has included
inspection and testing of the company's physical security systems,
verification of the company's compliance with state and local laws, and
a review of the company's background and history. Therefore, pursuant
to 21 U.S.C. 952(a) and 958(a), and in accordance with 21 CFR 1301.34,
the above named company is granted registration as an importer of the
basic class of controlled substance listed.
Dated: March 29, 2005.
William J. Walker,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. 05-6798 Filed 4-5-05; 8:45 am]
BILLING CODE 4410-09-P
